M. Schwartz
- Topics
- Parkinson's Disease and Spinal Disorders (3 papers)Botulinum Toxin and Related Neurological Disorders (2 papers)Parkinson's Disease Mechanisms and Treatments (2 papers)
- Partner nations
- IsraelBelgiumUnited States
In The Last Decade
M. Schwartz
13 papers receiving 257 citations
Peers
Comparison fields: 5 of 69
- Neurology 82
- Psychiatry and Mental health 70
- Rheumatology 55
- Clinical Psychology 43
- Genetics 29
Countries citing papers authored by M. Schwartz
This map shows the geographic impact of M. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Schwartz more than expected).
Fields of papers citing papers by M. Schwartz
This network shows the impact of papers produced by M. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Schwartz. The network helps show where M. Schwartz may publish in the future.
Co-authorship network of co-authors of M. Schwartz
This figure shows the co-authorship network connecting the top 25 collaborators of M. Schwartz. A scholar is included among the top collaborators of M. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Schwartz. M. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 23 | |
| 3 | 1 | |
| 4 | Lymphocytes, autoantibodies and psychosis--coincidence versus etiological factor: an update. | 13 |
| 5 | 1 | |
| 6 | 6 | |
| 7 | 132 | |
| 8 | 9 | |
| 9 | Rabbit syndrome and tardive dyskinesia: two complications of chronic neuroleptic treatment. | 12 |
| 10 | No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients. | 24 |
| 11 | 6 | |
| 12 | [Psychiatric manifestations in Wilson's disease]. | 11 |
| 13 | 10 | |
| 14 | 16 | |
| 15 | 2 | |
| 16 | [Papillitis necroticans renalis; 20 cases from a medical department; a disease of possible rising incidence]. | 1 |
About M. Schwartz
M. Schwartz is a scholar working on Medical Terminology, Neurology and Biological Psychiatry, having authored 16 papers that have together received 267 indexed citations. Recurring topics across this work include Parkinson's Disease and Spinal Disorders (3 papers), Botulinum Toxin and Related Neurological Disorders (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). The work is most often cited by research in Biological Psychiatry (14 citations), Neurology (82 citations) and Psychiatry and Mental health (70 citations). M. Schwartz has collaborated with scholars based in Israel, Belgium and United States. Frequent co-authors include B Sharf, Henry Silver, B Weller, A. Sheinkman, Ilanit Tal, D Golan, David Attias, Barbara F. Sharf, Sigrun Fuchs and Hillel Pratt. Their work appears in journals such as Scientific Reports, Journal of Neurology Neurosurgery & Psychiatry and Clinical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.